✓
Trusted by 40% of Fortune 1000
Clovis Oncology, Inc.
Clovis Oncology, Inc. has filed for bankruptcy due to the combination of poor sales tied to its cancer drug, Rubraca, and a significant debt load.
Clovis Oncology, Inc. has filed for bankruptcy due to the combination of poor sales tied to its cancer drug, Rubraca, and a significant debt load.